PT Kalbe Farma Tbk. (PTKFF) versus The Competition Financial Review

Profitability

This table compares PT Kalbe Farma Tbk. and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PT Kalbe Farma Tbk.	N/A	N/A	N/A
PT Kalbe Farma Tbk. Competitors	-2,478.03%	-254.07%	-16.90%

Institutional & Insider Ownership

21.6% of PT Kalbe Farma Tbk. shares are owned by institutional investors. Comparatively, 32.7% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 14.0% of shares of all “Pharmaceuticals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares PT Kalbe Farma Tbk. and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PT Kalbe Farma Tbk.	N/A	N/A	0.00
PT Kalbe Farma Tbk. Competitors	$3.47 billion	$3.10 billion	513.36

PT Kalbe Farma Tbk.’s competitors have higher revenue and earnings than PT Kalbe Farma Tbk.. PT Kalbe Farma Tbk. is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Dividends

PT Kalbe Farma Tbk. pays an annual dividend of $14.45 per share and has a dividend yield of 35,900.6%. PT Kalbe Farma Tbk. pays out 33.2% of its earnings in the form of a dividend. As a group, “Pharmaceuticals” companies pay a dividend yield of 3.6% and pay out 47.7% of their earnings in the form of a dividend. PT Kalbe Farma Tbk. is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.

Summary

PT Kalbe Farma Tbk. beats its competitors on 5 of the 9 factors compared.

PT Kalbe Farma Tbk. Company Profile

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.